ICH Celebrates 20 Years
ICH Celebrates 20 Years with a Refreshed and Revitalised New Visual Identity.
Showing 380 results.
ICH Celebrates 20 Years with a Refreshed and Revitalised New Visual Identity.
The ICH Steering Committee has approved the development of a new ICH E2C(R2) Guideline to replace the current ICH E2C(R1) Guideline “Clinical Safety Data Management: Periodic Safety Update Reports for Marketed Drugs”.
As part of its 20th Anniversary celebration, ICH is pleased to announce the launch of a new logo and a new look for the ICH website.
ICH Looks Ahead to the Next Decade: Further Expansion to Non-ICH Regions.
The ICH Steering Committee has agreed to open ICH technical working groups to active participation from experts from non-ICH member regions and countries of the ICH GCG.
The Value and Benefits of ICH to Drug Regulatory Authorities - Advancing Harmonization for Better Health. This publication has been developed on the occasion of ICH's 20th anniversary.
Special Session for non-ICH Members of ICH Global Cooperation Group Held at Board Meeting. Fukuoka, 7 November 2010 – The MedDRA Management Board met in Fukuoka, Japan on 6 – 7 November 2010.
An important landmark has been achieved with the addition of a general statement indicating interchangeability pertinent to Health Canada in all Q4B topic-specific annexes.